This article is from the source 'bbc' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.bbc.co.uk/news/51980731

The article has changed 32 times. There is an RSS feed of changes available.

Version 13 Version 14
Coronavirus and hydroxychloroquine: What do we know? Coronavirus and hydroxychloroquine: What do we know?
(4 days later)
US President Donald Trump has said he's taking the malaria drug hydroxychloroquine as a preventative measure against Covid-19, although scientists have warned about side effects. A drug normally used to treat malaria has been touted as a potential treatment for coronavirus.
Studies are underway to examine if hydroxychloroquine (and a related drug chloroquine) are effective against the coronavirus. Yet scientists have warned about side effects and the World Health Organization (WHO) has temporarily halted several studies around the world because of safety fears.
US President Donald Trump previously said he was taking hydroxychloroquine as a preventative measure against Covid-19, but has now stopped.
Other trials are underway to examine if hydroxychloroquine (and a related drug chloroquine) are effective against the coronavirus.
We've looked at what we know so far about these drugs.We've looked at what we know so far about these drugs.
Who's raised concerns about using them?Who's raised concerns about using them?
The World Health Organization has said it's concerned by reports of individuals self-medicating and causing themselves serious harm.The World Health Organization has said it's concerned by reports of individuals self-medicating and causing themselves serious harm.
These safety concerns have been echoed by a former top US health official.These safety concerns have been echoed by a former top US health official.
Dr Rick Bright, who was removed from his post in April leading the government's vaccine development efforts, says President Trump's focus on these drugs has been "extremely distracting to dozens of federal scientists".Dr Rick Bright, who was removed from his post in April leading the government's vaccine development efforts, says President Trump's focus on these drugs has been "extremely distracting to dozens of federal scientists".
And the US Food and Drugs Administration, which granted emergency approval for using them in certain settings only, has also warned about some possible side effects.And the US Food and Drugs Administration, which granted emergency approval for using them in certain settings only, has also warned about some possible side effects.
Is there evidence they might treat Covid-19?Is there evidence they might treat Covid-19?
President Trump has previously referred to the potential of hydroxychloroquine in White House briefings. At a press conference in April, he said: "What do you have to lose? Take it." President Trump has referred to the potential of hydroxychloroquine in White House briefings. At a press conference in April, he said: "What do you have to lose? Take it."
And Brazilian President Jair Bolsonaro claimed in a video that "hydroxychloroquine is working in all places", although that was subsequently removed by Facebook for breaching its misinformation guidelines. Brazilian President Jair Bolsonaro claimed in a video that "hydroxychloroquine is working in all places". It was subsequently removed by Facebook for breaching its misinformation guidelines.
The publicity given to these drugs led to a global surge in demand for them. Following Mr Trump's comments, there was a sharp increase reported in prescriptions in the US for both chloroquine and hydroxychloroquine.
Following Mr Trump's comments in late March, there was a sharp increase reported in prescriptions in the US for both chloroquine and hydroxychloroquine. The publicity given to these drugs has also led to a global surge in demand for them.
Tablets containing chloroquine have long been used in the treatment of malaria to reduce fever and inflammation, and the hope is that they can also work against the virus that causes Covid-19. Tablets containing chloroquine have long been used in the treatment of malaria to reduce fever and inflammation, and the hope has been that they can also work against the virus that causes Covid-19.
There are ongoing trials in various countries on using the drugs to prevent the illness. As part of these studies, frontline workers who are highly exposed to the virus are taking it as a prophylactic.There are ongoing trials in various countries on using the drugs to prevent the illness. As part of these studies, frontline workers who are highly exposed to the virus are taking it as a prophylactic.
A trial has begun across Europe, Africa, Asia and South America, testing 40,000 people with either hydroxychloroquine, chloroquine or a placebo to see if it's effective on those who might be exposed to the virus.A trial has begun across Europe, Africa, Asia and South America, testing 40,000 people with either hydroxychloroquine, chloroquine or a placebo to see if it's effective on those who might be exposed to the virus.
Other studies are looking into whether it can help patients who already have Covid-19.Other studies are looking into whether it can help patients who already have Covid-19.
In the US, various trials are under way for a combination of drugs including chloroquine, hydroxychloroquine and an antibiotic called azithromycin, for treating Covid-19 patients.In the US, various trials are under way for a combination of drugs including chloroquine, hydroxychloroquine and an antibiotic called azithromycin, for treating Covid-19 patients.
But so far, there is insufficient evidence from these trials as to their effective use in either prevention or in treatment. A recent large-scale study published in The Lancet medical journal that reviewed the medical records of coronavirus patients found that there were no benefits to taking these anti-malarial drugs and could even increase the risk of death and heart problems.
But so far, there is insufficient evidence from this research to draw conclusively as to their effective use in either prevention or in treatment.
"We need larger, high-quality randomised clinical trials in order to better evaluate their effectiveness," says University of Oxford's Kome Gbinigie, author of a report on anti-malarial testing for Covid-19."We need larger, high-quality randomised clinical trials in order to better evaluate their effectiveness," says University of Oxford's Kome Gbinigie, author of a report on anti-malarial testing for Covid-19.
There are also risks of serious side effects, including renal and liver damage.There are also risks of serious side effects, including renal and liver damage.
Which countries authorised their use?Which countries authorised their use?
In late March, the US Food and Drugs Administration (FDA) has granted "emergency use" authorisation for these drugs in the treatment of Covid-19 for a limited number of hospitalised cases.In late March, the US Food and Drugs Administration (FDA) has granted "emergency use" authorisation for these drugs in the treatment of Covid-19 for a limited number of hospitalised cases.
The FDA is not saying they definitely work. But it does mean that in specific circumstances, hospitals can request and use the medicines from government stockpiles for use in Covid-19 treatment.The FDA is not saying they definitely work. But it does mean that in specific circumstances, hospitals can request and use the medicines from government stockpiles for use in Covid-19 treatment.
But on 24 April, the FDA also issued a warning about the dangers of using the substances because of reports of heart rhythm problems in patients.But on 24 April, the FDA also issued a warning about the dangers of using the substances because of reports of heart rhythm problems in patients.
Other countries are also deploying these anti-malarial drugs to varying degrees.Other countries are also deploying these anti-malarial drugs to varying degrees.
Brazil has relaxed its restrictions on the drugs to allow doctors to prescribe them to patients with mild coronavirus symptoms, not just those in a serious condition in hospital.Brazil has relaxed its restrictions on the drugs to allow doctors to prescribe them to patients with mild coronavirus symptoms, not just those in a serious condition in hospital.
France has authorised doctors to prescribe them for patients with Covid-19, but the country's medical watchdog has also warned of side effects.France has authorised doctors to prescribe them for patients with Covid-19, but the country's medical watchdog has also warned of side effects.
India's health ministry recommended the use of hydroxychloroquine as a preventative treatment for healthcare workers, as well as households in contact with confirmed cases if they have a prescription from a doctor. The Indian government has expanded the use of the drug as a preventative medicine for healthcare workers in non-coronavirus environments and police working in areas with high rates of Covid-19.
However, India's government research body has warned against the unrestricted usage of the anti-malarial drug and said it was "experimental" and only for emergency situations. It was previously just for those working among coronavirus patients and households in contact with confirmed cases if they have a prescription from a doctor.
Uses of the drug will continue to be under medical supervision, as India's government research body has previously warned against the unrestricted usage of the anti-malarial drug
Several Middle Eastern countries have authorised its use or are conducting trials.Several Middle Eastern countries have authorised its use or are conducting trials.
Is there enough available?
As interest in these drugs has grown as a potential treatment for Covid-19, many countries have seen high demand and shortages.
Chloroquine and its derivatives have long been widely available in pharmacies, particularly in developing countries, for the treatment of malaria.
This is despite their declining efficacy against malaria, as the disease has become increasingly resistant.
A number of countries restricted sales so that chloroquine was only available on prescription or in hospitals.
India - a major producer of these anti-malarial drugs - at one point stopped exports. But it lifted the ban after President Trump made a personal plea to India's Prime Minister, Narendra Modi.
In Nigeria, households still regularly use tablets containing chloroquine for treating malaria, even though it was banned in 2005 for first-line use because of its declining effectiveness.
But news of its possible use against Covid-19 led to growing demand, and the Nigerian Centres for Disease Control told people to stop taking it.
Read more from Reality CheckRead more from Reality Check
Send us your questionsSend us your questions
Follow us on TwitterFollow us on Twitter